ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
Saved in:
| Title: | ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients. |
|---|---|
| Authors: | Meredith DM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Cooley LD; Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, University of Missouri School of Medicine, Kansas City, Missouri., Dubuc A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Morrissette J; Pathology and Laboratory Medicine, Division of Precision and Computational Diagnostics, Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania., Sussman RT; Pathology and Laboratory Medicine, Division of Precision and Computational Diagnostics, Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania., Nasrallah MP; Pathology and Laboratory Medicine, Division of Neuropathology, Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania., Rathbun P; Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois., Yap KL; Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois., Wadhwani N; Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois., Bao L; Department of Pathology School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Wolff DJ; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina., Ida C; Department of Pathology, School of Medicine, Mayo clinic, Scottsdale, Arizona., Sukhanova M; Department of Pathology, Northwestern University Feinberg School of Medicine, Lurie Cancer Center, Chicago, Illinois., Horbinski C; Department of Pathology, Northwestern University Feinberg School of Medicine, Lurie Cancer Center, Chicago, Illinois., Jennings LJ; Department of Pathology, Northwestern University Feinberg School of Medicine, Lurie Cancer Center, Chicago, Illinois., Farooqi M; Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, University of Missouri School of Medicine, Kansas City, Missouri., Gener M; Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, University of Missouri School of Medicine, Kansas City, Missouri., Ginn K; Division of Hematology/Oncology/Blood and Marrow Transplant, Children's Mercy Kansas City & School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri., Kam KL; Department of Pathology, Beaumont Hospital, Royal Oak, Michigan., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alexandrescu S; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Brat D; Department of Pathology, Northwestern University Feinberg School of Medicine, Lurie Cancer Center, Chicago, Illinois., Lu X; Department of Pathology, Northwestern University Feinberg School of Medicine, Lurie Cancer Center, Chicago, Illinois. Electronic address: xinyan.lu@northwestern.edu. |
| Source: | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2023 Nov; Vol. 36 (11), pp. 100294. Date of Electronic Publication: 2023 Jul 31. |
| Publication Type: | Meta-Analysis; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
